IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CROHN’S DISEASE: A PHASE 2 STUDY ANALYSIS USING THE SF-36

Vipul Jairath  ¹     Toshifumi Hibi  ²     Lai Shan Chan  ³     Theresa Hunter Gibble  ³     Hilde Carlier  ³     Xian Zhou  ⁴     Marijana Protic  ⁴     David T. Rubin  ^5    
1 Western University & London Health Sciences Centre, Ontario
² Kitasato Institute Hospital IBD Research and Treatment, Tokyo, Japan
³ Eli Lilly and Company, Indianapolis, United States
⁴ Syneos Health, Morrisville, United States
⁵ University of Chicago Medicine, Chicago, United States

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)